ArticleAME case reports2025

Adjusted gemcitabine plus S-1 regimen as first‑line chemotherapy in unresectable advanced pancreatic cancer: a long-term survival case report.

Yu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.